Quest Diagnostics reports third quarter 2014 financial results
Quest Diagnostics reported revenues from continuing operations of $1.9 billion, up 6.5% versus the prior year period, and adjusted income from continuing operations grew to $161 million, or $1.10 per diluted share, compared to $154 million, or $1.02 per diluted share, for 2013. October 23, 2014